Carriers of the A allele presented with 20.170 mg/dL elevated triglyceride (TG) levels compared to non-carriers as adherence to this dietary pattern increased, after adjusting for age, gender, energy intake, NAFLD diagnosis, adherence to “Prudent” dietary pattern, TM6SF2-rs58542926, and antilipidemic drug therapy (p = 0.007) (Figure 1). This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.